Report Detail

Other Global Continuous Blood Glucose Monitoring Market Insights, Forecast to 2025

  • RnM3412384
  • |
  • 13 May, 2019
  • |
  • Global
  • |
  • 113 Pages
  • |
  • QYResearch
  • |
  • Other

Continuous blood glucose monitoring system is a medical device which is used to track and monitor glucose levels in the blood. This system will help the patients to continuously track & monitor the fluctuations in the sugar level. The various components of continuous blood glucose monitoring system are insulin pumps, sensors, and transmitters and receivers among other to monitor it in real time.
North America region is expected to dominate the continuous blood glucose monitoring system market in the global arena due to growing FDA approvals and increase in number of diabetic patients in the US. However, rising economies of China & India and enhancing healthcare infrastructure in APAC is expected to boost the demand for continuous blood glucose monitoring system market in the future.
The global Continuous Blood Glucose Monitoring market is valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025. The objectives of this study are to define, segment, and project the size of the Continuous Blood Glucose Monitoring market based on company, product type, end user and key regions.

This report studies the global market size of Continuous Blood Glucose Monitoring in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Continuous Blood Glucose Monitoring in these regions.
This research report categorizes the global Continuous Blood Glucose Monitoring market by top players/brands, region, type and end user. This report also studies the global Continuous Blood Glucose Monitoring market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors.

The following manufacturers are covered in this report, with sales, revenue, market share for each company:
Roche
Lifescan
Medtronic
Bayer AG
Abbott
Terumo
Dexcom
Echo Therapeutics
B. Braun Melsungen
Arkray
Cellnovo Group
Nemaura
Tandem Diabetes Care

Market size by Product
Self-Monitoring Blood Glucose Systems
Continuous Glucose Monitoring Systems
Market size by End User
Hospitals
Clinics
Home Care

Market size by Region
North America
United States
Canada
Mexico
Asia-Pacific
China
India
Japan
South Korea
Australia
Indonesia
Singapore
Malaysia
Philippines
Thailand
Vietnam
Europe
Germany
France
UK
Italy
Spain
Russia
Central & South America
Brazil
Rest of Central & South America
Middle East & Africa
GCC Countries
Turkey
Egypt
South Africa

The study objectives of this report are:
To study and analyze the global Continuous Blood Glucose Monitoring market size (value & volume) by company, key regions, products and end user, breakdown data from 2014 to 2018, and forecast to 2025.
To understand the structure of Continuous Blood Glucose Monitoring market by identifying its various subsegments.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
Focuses on the key global Continuous Blood Glucose Monitoring companies, to define, describe and analyze the sales volume, value, market share, market competition landscape and recent development.
To project the value and sales volume of Continuous Blood Glucose Monitoring submarkets, with respect to key regions.
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

In this study, the years considered to estimate the market size of Continuous Blood Glucose Monitoring are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025

This report includes the estimation of market size for value (million US$) and volume (K Units). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Continuous Blood Glucose Monitoring market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.

For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.


Table of Contents

    1 Study Coverage

    • 1.1 Continuous Blood Glucose Monitoring Product
    • 1.2 Market Segments
    • 1.3 Key Manufacturers Covered
    • 1.4 Market by Type
      • 1.4.1 Global Continuous Blood Glucose Monitoring Market Size Growth Rate by Product
      • 1.4.2 Self-Monitoring Blood Glucose Systems
      • 1.4.3 Continuous Glucose Monitoring Systems
    • 1.5 Market by End User
      • 1.5.1 Global Continuous Blood Glucose Monitoring Market Size Growth Rate by End User
      • 1.5.2 Hospitals
      • 1.5.3 Clinics
      • 1.5.4 Home Care
    • 1.6 Study Objectives
    • 1.7 Years Considered

    2 Executive Summary

    • 2.1 Global Continuous Blood Glucose Monitoring Market Size
      • 2.1.1 Global Continuous Blood Glucose Monitoring Revenue 2014-2025
      • 2.1.2 Global Continuous Blood Glucose Monitoring Sales 2014-2025
    • 2.2 Continuous Blood Glucose Monitoring Growth Rate by Regions
      • 2.2.1 Global Continuous Blood Glucose Monitoring Sales by Regions
      • 2.2.2 Global Continuous Blood Glucose Monitoring Revenue by Regions

    3 Breakdown Data by Manufacturers

    • 3.1 Continuous Blood Glucose Monitoring Sales by Manufacturers
      • 3.1.1 Continuous Blood Glucose Monitoring Sales by Manufacturers
      • 3.1.2 Continuous Blood Glucose Monitoring Sales Market Share by Manufacturers
      • 3.1.3 Global Continuous Blood Glucose Monitoring Market Concentration Ratio (CR5 and HHI)
    • 3.2 Continuous Blood Glucose Monitoring Revenue by Manufacturers
      • 3.2.1 Continuous Blood Glucose Monitoring Revenue by Manufacturers (2014-2019)
      • 3.2.2 Continuous Blood Glucose Monitoring Revenue Share by Manufacturers (2014-2019)
    • 3.3 Continuous Blood Glucose Monitoring Price by Manufacturers
    • 3.4 Continuous Blood Glucose Monitoring Manufacturing Base Distribution, Product Types
      • 3.4.1 Continuous Blood Glucose Monitoring Manufacturers Manufacturing Base Distribution, Headquarters
      • 3.4.2 Manufacturers Continuous Blood Glucose Monitoring Product Type
      • 3.4.3 Date of International Manufacturers Enter into Continuous Blood Glucose Monitoring Market
    • 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

    4 Breakdown Data by Product

    • 4.1 Global Continuous Blood Glucose Monitoring Sales by Product
    • 4.2 Global Continuous Blood Glucose Monitoring Revenue by Product
    • 4.3 Continuous Blood Glucose Monitoring Price by Product

    5 Breakdown Data by End User

    • 5.1 Overview
    • 5.2 Global Continuous Blood Glucose Monitoring Breakdown Data by End User

    6 North America

    • 6.1 North America Continuous Blood Glucose Monitoring by Countries
      • 6.1.1 North America Continuous Blood Glucose Monitoring Sales by Countries
      • 6.1.2 North America Continuous Blood Glucose Monitoring Revenue by Countries
      • 6.1.3 United States
      • 6.1.4 Canada
      • 6.1.5 Mexico
    • 6.2 North America Continuous Blood Glucose Monitoring by Product
    • 6.3 North America Continuous Blood Glucose Monitoring by End User

    7 Europe

    • 7.1 Europe Continuous Blood Glucose Monitoring by Countries
      • 7.1.1 Europe Continuous Blood Glucose Monitoring Sales by Countries
      • 7.1.2 Europe Continuous Blood Glucose Monitoring Revenue by Countries
      • 7.1.3 Germany
      • 7.1.4 France
      • 7.1.5 UK
      • 7.1.6 Italy
      • 7.1.7 Russia
    • 7.2 Europe Continuous Blood Glucose Monitoring by Product
    • 7.3 Europe Continuous Blood Glucose Monitoring by End User

    8 Asia Pacific

    • 8.1 Asia Pacific Continuous Blood Glucose Monitoring by Countries
      • 8.1.1 Asia Pacific Continuous Blood Glucose Monitoring Sales by Countries
      • 8.1.2 Asia Pacific Continuous Blood Glucose Monitoring Revenue by Countries
      • 8.1.3 China
      • 8.1.4 Japan
      • 8.1.5 Korea
      • 8.1.6 India
      • 8.1.7 Australia
      • 8.1.8 Indonesia
      • 8.1.9 Malaysia
      • 8.1.10 Philippines
      • 8.1.11 Thailand
      • 8.1.12 Vietnam
      • 8.1.13 Singapore
    • 8.2 Asia Pacific Continuous Blood Glucose Monitoring by Product
    • 8.3 Asia Pacific Continuous Blood Glucose Monitoring by End User

    9 Central & South America

    • 9.1 Central & South America Continuous Blood Glucose Monitoring by Countries
      • 9.1.1 Central & South America Continuous Blood Glucose Monitoring Sales by Countries
      • 9.1.2 Central & South America Continuous Blood Glucose Monitoring Revenue by Countries
      • 9.1.3 Brazil
    • 9.2 Central & South America Continuous Blood Glucose Monitoring by Product
    • 9.3 Central & South America Continuous Blood Glucose Monitoring by End User

    10 Middle East and Africa

    • 10.1 Middle East and Africa Continuous Blood Glucose Monitoring by Countries
      • 10.1.1 Middle East and Africa Continuous Blood Glucose Monitoring Sales by Countries
      • 10.1.2 Middle East and Africa Continuous Blood Glucose Monitoring Revenue by Countries
      • 10.1.3 GCC Countries
      • 10.1.4 Turkey
      • 10.1.5 Egypt
      • 10.1.6 South Africa
    • 10.2 Middle East and Africa Continuous Blood Glucose Monitoring by Product
    • 10.3 Middle East and Africa Continuous Blood Glucose Monitoring by End User

    11 Company Profiles

    • 11.1 Roche
      • 11.1.1 Roche Company Details
      • 11.1.2 Company Business Overview
      • 11.1.3 Roche Continuous Blood Glucose Monitoring Sales, Revenue and Gross Margin (2014-2019)
      • 11.1.4 Roche Continuous Blood Glucose Monitoring Products Offered
      • 11.1.5 Roche Recent Development
    • 11.2 Lifescan
      • 11.2.1 Lifescan Company Details
      • 11.2.2 Company Business Overview
      • 11.2.3 Lifescan Continuous Blood Glucose Monitoring Sales, Revenue and Gross Margin (2014-2019)
      • 11.2.4 Lifescan Continuous Blood Glucose Monitoring Products Offered
      • 11.2.5 Lifescan Recent Development
    • 11.3 Medtronic
      • 11.3.1 Medtronic Company Details
      • 11.3.2 Company Business Overview
      • 11.3.3 Medtronic Continuous Blood Glucose Monitoring Sales, Revenue and Gross Margin (2014-2019)
      • 11.3.4 Medtronic Continuous Blood Glucose Monitoring Products Offered
      • 11.3.5 Medtronic Recent Development
    • 11.4 Bayer AG
      • 11.4.1 Bayer AG Company Details
      • 11.4.2 Company Business Overview
      • 11.4.3 Bayer AG Continuous Blood Glucose Monitoring Sales, Revenue and Gross Margin (2014-2019)
      • 11.4.4 Bayer AG Continuous Blood Glucose Monitoring Products Offered
      • 11.4.5 Bayer AG Recent Development
    • 11.5 Abbott
      • 11.5.1 Abbott Company Details
      • 11.5.2 Company Business Overview
      • 11.5.3 Abbott Continuous Blood Glucose Monitoring Sales, Revenue and Gross Margin (2014-2019)
      • 11.5.4 Abbott Continuous Blood Glucose Monitoring Products Offered
      • 11.5.5 Abbott Recent Development
    • 11.6 Terumo
      • 11.6.1 Terumo Company Details
      • 11.6.2 Company Business Overview
      • 11.6.3 Terumo Continuous Blood Glucose Monitoring Sales, Revenue and Gross Margin (2014-2019)
      • 11.6.4 Terumo Continuous Blood Glucose Monitoring Products Offered
      • 11.6.5 Terumo Recent Development
    • 11.7 Dexcom
      • 11.7.1 Dexcom Company Details
      • 11.7.2 Company Business Overview
      • 11.7.3 Dexcom Continuous Blood Glucose Monitoring Sales, Revenue and Gross Margin (2014-2019)
      • 11.7.4 Dexcom Continuous Blood Glucose Monitoring Products Offered
      • 11.7.5 Dexcom Recent Development
    • 11.8 Echo Therapeutics
      • 11.8.1 Echo Therapeutics Company Details
      • 11.8.2 Company Business Overview
      • 11.8.3 Echo Therapeutics Continuous Blood Glucose Monitoring Sales, Revenue and Gross Margin (2014-2019)
      • 11.8.4 Echo Therapeutics Continuous Blood Glucose Monitoring Products Offered
      • 11.8.5 Echo Therapeutics Recent Development
    • 11.9 B. Braun Melsungen
      • 11.9.1 B. Braun Melsungen Company Details
      • 11.9.2 Company Business Overview
      • 11.9.3 B. Braun Melsungen Continuous Blood Glucose Monitoring Sales, Revenue and Gross Margin (2014-2019)
      • 11.9.4 B. Braun Melsungen Continuous Blood Glucose Monitoring Products Offered
      • 11.9.5 B. Braun Melsungen Recent Development
    • 11.10 Arkray
      • 11.10.1 Arkray Company Details
      • 11.10.2 Company Business Overview
      • 11.10.3 Arkray Continuous Blood Glucose Monitoring Sales, Revenue and Gross Margin (2014-2019)
      • 11.10.4 Arkray Continuous Blood Glucose Monitoring Products Offered
      • 11.10.5 Arkray Recent Development
    • 11.11 Cellnovo Group
    • 11.12 Nemaura
    • 11.13 Tandem Diabetes Care

    12 Future Forecast

    • 12.1 Continuous Blood Glucose Monitoring Market Forecast by Regions
      • 12.1.1 Global Continuous Blood Glucose Monitoring Sales Forecast by Regions 2019-2025
      • 12.1.2 Global Continuous Blood Glucose Monitoring Revenue Forecast by Regions 2019-2025
    • 12.2 Continuous Blood Glucose Monitoring Market Forecast by Product
      • 12.2.1 Global Continuous Blood Glucose Monitoring Sales Forecast by Product 2019-2025
      • 12.2.2 Global Continuous Blood Glucose Monitoring Revenue Forecast by Product 2019-2025
    • 12.3 Continuous Blood Glucose Monitoring Market Forecast by End User
    • 12.4 North America Continuous Blood Glucose Monitoring Forecast
    • 12.5 Europe Continuous Blood Glucose Monitoring Forecast
    • 12.6 Asia Pacific Continuous Blood Glucose Monitoring Forecast
    • 12.7 Central & South America Continuous Blood Glucose Monitoring Forecast
    • 12.8 Middle East and Africa Continuous Blood Glucose Monitoring Forecast

    13 Market Opportunities, Challenges, Risks and Influences Factors Analysis

    • 13.1 Market Opportunities and Drivers
    • 13.2 Market Challenges
    • 13.3 Market Risks/Restraints
    • 13.4 Macroscopic Indicators

    14 Value Chain and Sales Channels Analysis

    • 14.1 Value Chain Analysis
    • 14.2 Continuous Blood Glucose Monitoring Customers
    • 14.3 Sales Channels Analysis
      • 14.3.1 Sales Channels
      • 14.3.2 Distributors

    15 Research Findings and Conclusion

      16 Appendix

      • 16.1 Research Methodology
        • 16.1.1 Methodology/Research Approach
        • 16.1.2 Data Source
      • 16.2 Author Details

      Summary:
      Get latest Market Research Reports on Continuous Blood Glucose Monitoring . Industry analysis & Market Report on Continuous Blood Glucose Monitoring is a syndicated market report, published as Global Continuous Blood Glucose Monitoring Market Insights, Forecast to 2025. It is complete Research Study and Industry Analysis of Continuous Blood Glucose Monitoring market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

      Last updated on

      REPORT YOU MIGHT BE INTERESTED

      Purchase this Report

      $4,900.00
      $7,350.00
      $9,800.00
      3,934.70
      5,902.05
      7,869.40
      4,596.20
      6,894.30
      9,192.40
      756,707.00
      1,135,060.50
      1,513,414.00
      409,836.00
      614,754.00
      819,672.00
      Credit card Logo

      Related Reports


      Reason to Buy

      Request for Sample of this report